Wesbanco Trust And Investments »

Intellia Therapeutics shares owned by Wesbanco Trust And Investments

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Wesbanco Trust And Investments from 13F filings

Historical chart of Wesbanco Trust And Investments investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by Wesbanco Trust And Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by Wesbanco Trust And Investments

Quarter filed Position value Share count Share price at filing
2025-12-31 $575k 64k 8.99

More positions owned by Wesbanco Trust And Investments

Apple Common Stock (AAPL)
Microsoft Common Stock (MSFT)
Ishares Mutual Funds - (AGG)
Broadcom Common Stock (AVGO)
Alphabet Common Stock (GOOGL)
Jp Morgan Chase Common Stock (JPM)
Amazon.com Common Stock (AMZN)
Nvidia Corp Common Stock (NVDA)
Meta Platforms Common Stock (META)
Wesbanco Common Stock (WSBC)
Ishares Mutual Funds - (ACWX)
Chevron Corporation Common Stock (CVX)
Vanguard Mutual Funds - (VO)
Exxon Mobil Corp Common Stock (XOM)
Procter & Gamble Common Stock (PG)

View all positions for Wesbanco Trust And Investments

Top funds holding Intellia Therapeutics

ARK Investment Management
Vanguard Group
BlackRock
State Street Corporation
Regeneron Pharmaceuticals
Baker Bros. Advisors
Geode Capital Management
Two Sigma Investments
D. E. Shaw & Co
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Two Sigma Advisers
Dimensional Fund Advisors
Susquehanna International
FMR

View all funds holding Intellia Therapeutics